MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

17 May 2026 Evaluate
The company witnessed a 23.24% growth in the revenue at Rs. 1326.65 millions for the quarter ended March 2026 as compared to Rs. 1076.48 millions during the year-ago period.Net Profit witnessed a 724.02% growth almost the double from Rs. 10.95 millions to Rs. 90.23  millions  of same quarter last year.The company reported a good operating profit of 261.66 millions compared to 91.98 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1326.65 1076.48 23.24 4962.96 3664.15 35.45 4962.96 3664.15 35.45
Other Income -3.69 12.95 -128.49 35.28 35.61 -0.93 35.28 35.61 -0.93
PBIDT 261.66 91.98 184.47 928.58 294.05 215.79 928.58 294.05 215.79
Interest 14.38 3.88 270.62 28.51 12.90 121.01 28.51 12.90 121.01
PBDT 247.28 88.10 180.68 900.07 281.15 220.14 900.07 281.15 220.14
Depreciation 97.53 72.56 34.41 368.42 276.54 33.22 368.42 276.54 33.22
PBT 149.75 15.54 863.64 531.65 4.61 11432.54 531.65 4.61 11432.54
TAX 59.52 4.59 1196.73 140.83 1.34 10409.70 140.83 1.34 10409.70
Deferred Tax 33.82 4.73 615.01 40.16 1.32 2942.42 40.16 1.32 2942.42
PAT 90.23 10.95 724.02 390.82 3.27 11851.68 390.82 3.27 11851.68
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 19.72 8.54 130.83 18.71 8.03 133.15 18.71 8.03 133.15
Peers
Company Name CMP
Godrej Industries 1073.40
SRF 2490.00
BASF India 3493.40
Pidilite Inds. 1499.05
Tata Chemicals 641.65
View more..